At Cell Therapy Sciences not only do we work with advanced, state-of-the-art cell-based technology, but we also conduct our own research, working with collaborators in both academia and veterinary practice.
Watch our short video below to learn more. You can also find details of our published abstracts and papers on our publications page.
Extensive evidence of efficacy and safety when using CTSL preparations of autologous stem cells in regenerative medicine treatment protocols, has been published in one of the largest clinical studies conducted to date in musculoskeletal conditions in dogs (Armitage et al Efficacy of autologous mesenchymal stromal cell treatment for chronic degenerative musculoskeletal conditions in dogs: A retrospective study” Sec. Veterinary Regenerative Medicine Vet. Sci., 13 January 2023).
Efficacy of autologous stem cells:
Clinical study in 245 dogs
Stem Cell Quality: At CTSL we believe that high quality, autologous culture-expanded stem cells provide the highest probability of effectiveness and the highest standards of safety for veterinary patients; this is not the same for all stem cell options such as same-day "stem cells"
or SVF.
Not all Stem Cell Therapies are the same.
Culture-expanded autologous MSCs allow for standardized, quality controlled therapies
Stem Cells in Arthritic Joint Fluid:
We have demonstrated that the activity and viability of canine adipose-derived, mesenchymal stem cells, is NOT negatively impacted when exposed to canine osteoarthritic synovial fluid.
No Negative Impact of OA Joint Fluid on Stem Cell Viability
If you would like to arrange an in-clinic CPD or register your interest in forthcoming CPD Events please contact us via email.